- All sections
- C - Chemistry; metallurgy
- C07K - Peptides
- C07K 1/16 - Extraction; Separation; Purification by chromatography
Patent holdings for IPC class C07K 1/16
Total number of patents in this class: 1027
10-year publication summary
|
82
|
66
|
74
|
62
|
101
|
83
|
108
|
95
|
97
|
30
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Regeneron Pharmaceuticals, Inc. | 3650 |
51 |
| Bio-Rad Laboratories, Inc. | 1592 |
27 |
| Abbvie Inc. | 1808 |
24 |
| Cytiva BioProcess R&D AB | 287 |
24 |
| Genentech, Inc. | 3742 |
23 |
| EMD Millipore Corporation | 657 |
23 |
| Amgen Inc. | 3779 |
22 |
| Genzyme Corporation | 1205 |
19 |
| Plasma Technologies, LLC | 30 |
16 |
| Kashiv Biosciences, LLC | 100 |
15 |
| Hoffmann-La Roche Inc. | 3060 |
14 |
| F. Hoffmann-La Roche AG | 7958 |
13 |
| Merck Patent GmbH | 5909 |
9 |
| Cargill, Incorporated | 2835 |
9 |
| Takeda Pharmaceutical Company Limited | 2961 |
8 |
| Sartorius Stedim Biotech GmbH | 774 |
8 |
| Bristol-myers Squibb Company | 5080 |
7 |
| Hybio Pharmaceutical Co., Ltd. | 119 |
7 |
| Boehringer Ingelheim International GmbH | 4629 |
6 |
| Agency for Science, Technology and Research | 3512 |
6 |
| Other owners | 696 |